Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Identification of Serum Lactate Dehydrogenase (LDH) As an Independent Prognostic Biomarker in Polycythemia Vera

Ayalew Tefferi, MD, Daniela Barraco, MD, Sonia Cerquozzi, MD, Terra L. Lasho, PhD, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Animesh Pardanani, MBBS, PhD, Naseema Gangat, MBBS

Blood (2016) 128 (22): 3111.

https://doi.org/10.1182/blood.V128.22.3111.3111

Published: 2016

Journal Articles

Abnormal Karyotype and Prognosis in Polycythemia Vera: A Single Center Experience in 239 Informative Cases

Sonia Cerquozzi, MD, Daniela Barraco, MD, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Animesh Pardanani, MBBS, PhD, Naseema Gangat, MBBS, Ayalew Tefferi, MD

Blood (2016) 128 (22): 3115.

https://doi.org/10.1182/blood.V128.22.3115.3115

Published: 2016

Journal Articles

Prognostic Impact of Bone Marrow Fibrosis in Polycythemia Vera: Validation of the IWG-MRT Study and Additional Observations

Daniela Barraco, MD, Sonia Cerquozzi, MD, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Animesh Pardanani, MBBS, PhD, Naseema Gangat, MBBS, Ayalew Tefferi, MD

Blood (2016) 128 (22): 3129.

https://doi.org/10.1182/blood.V128.22.3129.3129

Published: 2016

Journal Articles

Monocytosis in Polycythemia Vera: Clinical and Molecular Correlates

Daniela Barraco, MD, Sonia Cerquozzi, MD, Naseema Gangat, MBBS, Mrinal M Patnaik, MBBS, Terra L. Lasho, PhD, Christy Finke, BS, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Animesh Pardanani, MBBS, PhD, Ayalew Tefferi, MD

Blood (2016) 128 (22): 4259.

https://doi.org/10.1182/blood.V128.22.4259.4259

Published: 2016

Journal Articles

Interim Analysis of the Myeloproliferative Disorders Research Consortium (MPD-RC) 112 Global Phase III Trial of Front Line Pegylated Interferon Alpha-2a Vs. Hydroxyurea in High Risk Polycythemia Vera and Essential Thrombocythemia

John O. Mascarenhas, MD MS, Josef T. Prchal, MD, Alessandro Rambaldi, MD, Ruben A. Mesa, MD, Dmitriy Berenzon, MD, Abdulraheem Yacoub, MD, Claire N. Harrison, DM, FRCP, FRCPath, Mary Frances McMullin, MD, Alessandro M. Vannucchi, MD PhD, Joanne C Ewing, PhD BMBS, BSc, FRPATH,, Casey L O'Connell, MD, Jean-Jacques Kiladjian, MD PhD, Adam Mead, MD PhD, Elliott F. Winton, MD, David S. Leibowitz, MD, Valerio De Stefano, Murat O. Arcasoy, MD, Craig M. Kessler, MD, Rosalind Catchatorian, Damiano Rondelli, MD, Richard T. Silver, MD, Ellen K. Ritchie, MD, Arnon Nagler, Marina Kremyanskaya, MD PhD, Richard F. Schlenk, MD, Rona Singer Weinberg, PhD, Mohamed E Salama, MD, Gianni Tognoni, Giuseppe Prosperini, Alessandra Di Lelio, Eliseo Serone, Lorenzo Marfisi, Jill Kleczko, Heidi E. Kosiorek, MS, Tiziano Barbui, MD, Amylou C. Dueck, PhD, Ronald Hoffman, MD

Blood (2016) 128 (22): 479.

https://doi.org/10.1182/blood.V128.22.479.479

Published: 2016

Journal Articles

Risk Factors for Arterial Versus Venous Thrombosis in Polycythemia Vera: Single Center Experience in 587 Patients

Sonia Cerquozzi, MD, Daniela Barraco, MD, Terra L. Lasho, PhD, Christy Finke, BS, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Animesh Pardanani, MBBS, PhD, Naseema Gangat, MBBS, Ayalew Tefferi, MD

Blood (2016) 128 (22): 948.

https://doi.org/10.1182/blood.V128.22.948.948

Published: 2016

Journal Articles

Ph-Negative Chronic Myeloproliferative Neoplasms – Population Analysis, a Single Center 10-years’ Experience

Vasily Shuvaev, MD, Irina Martynkevich, PhD, Alla Abdulkadyrova, Vera Udaleva, MD, Tatyana Zamotina, Mikhail Fominykh, Regina Golovchenko, Irina Zotova, Dzhariyat Shikhbabaeva, Lyubov Polushkina, Kudrat Abdulkadyrov, MD

Blood (2014) 124 (21): 5556.

https://doi.org/10.1182/blood.V124.21.5556.5556

Published: 2014

Journal Articles

Issues in Categorization and Management of Pediatric Patients with Myeloproliferative Neoplasms

Nicole Kucine, MD, Ross L. Levine, MD, James B. Bussel, MD

Blood (2014) 124 (21): 1843.

https://doi.org/10.1182/blood.V124.21.1843.1843

Published: 2014

Journal Articles

Inflammation and Thrombosis In Essential Thrombocythemia

Rossella Cacciola, M.D., Ernesto Di Francesco, Carmen Ferlito, Francesca Pezzella, Elisa Seria, Antonino Cipolla, Emma Cacciola, M.D.

Blood (2011) 118 (21): 5175.

https://doi.org/10.1182/blood.V118.21.5175.5175

Published: 2011

Journal Articles

Fatigue and Daily Life in Patients with Essential Thrombocythemia: Comparisons Between the USA and France in 447 Patients.

Ruben A. Mesa, MD, Jerome Rey, MD, Ayalew Tefferi, MD, Joyce Niblack, JD, Pascal Lenain, Emmanuel Raffoux, MD, Thierry De Revel, MD, PhD, John Camoriano, MD, Jean-Jacques Kiladjian, MD, PhD

Blood (2009) 114 (22): 2904.

https://doi.org/10.1182/blood.V114.22.2904.2904

Published: 2009

Journal Articles

A Retrospective Literature Review of Erythromelalgia and Myelorpoliferative Disorders

Cannon Milani, MD, Sheila Pascual, Gerald A. Colvin, DO

Blood (2008) 112 (11): 5264.

https://doi.org/10.1182/blood.V112.11.5264.5264

Published: 2008

Journal Articles

Heterogeneous JAK2V617F Allele Burden in Essential Thrombocytosis: Gender and Clinical Correlates.

Naveen Pemmaraju, MD, Alison R. Moliterno, MD, Donna Williams, PhD, Ophelia Rogers, Jerry L. Spivak, MD

Blood (2006) 108 (11): 2679.

https://doi.org/10.1182/blood.V108.11.2679.2679

Published: 2006

Journal Articles

The Use of the PFA-100 ® and Thromboelastograph in Assessing Haemostasis and Drug Efficacy in Essential Thrombocythemia.

Betty Y.Y. Cheung, MBBS, Kiran Parmar, MSc, Ghasem Yadegarfar, PhD, Beverley J. Hunt, MD, Claire N. Harrison, DM

Blood (2005) 106 (11): 4959.

https://doi.org/10.1182/blood.V106.11.4959.4959

Published: 2005

NARROW

Identification of Serum Lactate Dehydrogenase (LDH) As an Independent Prognostic Biomarker in Polycythemia Vera

Abnormal Karyotype and Prognosis in Polycythemia Vera: A Single Center Experience in 239 Informative Cases

Prognostic Impact of Bone Marrow Fibrosis in Polycythemia Vera: Validation of the IWG-MRT Study and Additional Observations

Monocytosis in Polycythemia Vera: Clinical and Molecular Correlates

Interim Analysis of the Myeloproliferative Disorders Research Consortium (MPD-RC) 112 Global Phase III Trial of Front Line Pegylated Interferon Alpha-2a Vs. Hydroxyurea in High Risk Polycythemia Vera and Essential Thrombocythemia

Risk Factors for Arterial Versus Venous Thrombosis in Polycythemia Vera: Single Center Experience in 587 Patients

Ph-Negative Chronic Myeloproliferative Neoplasms – Population Analysis, a Single Center 10-years’ Experience

Issues in Categorization and Management of Pediatric Patients with Myeloproliferative Neoplasms

Inflammation and Thrombosis In Essential Thrombocythemia

Fatigue and Daily Life in Patients with Essential Thrombocythemia: Comparisons Between the USA and France in 447 Patients.

A Retrospective Literature Review of Erythromelalgia and Myelorpoliferative Disorders

Heterogeneous JAK2V617F Allele Burden in Essential Thrombocytosis: Gender and Clinical Correlates.

The Use of the PFA-100 ® and Thromboelastograph in Assessing Haemostasis and Drug Efficacy in Essential Thrombocythemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only